UNSPSC 51151623: Bornaprine

This classification denotes an antimuscarinic agent with the molecular formula C21H31NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9M363FGA7J, chemically known as 2-phenylbicyclo(2.2.1)heptane-2-carboxylic acid, 3-(diethylamino)propyl ester but generally known as bornaprine, which bears US NIH Compound Identifier 30160. European Medicines Agency schedules Bornaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05874MIG.

UNSPSC 51151623 Bornaprine is a Commodity code that represents pharmaceutical products, though recent state and local procurement activity under this code shows a mismatch with the nominal classification. Seminole County, Florida's IFB60459723LAS, posted in June 2026, solicited naloxone and drug deactivation systems rather than bornaprine specifically, suggesting the code may be used broadly to tag pharmaceutical procurement or that the opportunity was miscoded. State and local governments soliciting under this code include county health departments and community health agencies pursuing emergency medical countermeasures and public health interventions, particularly those addressing opioid overdose response and harm reduction. The scope of work encompasses bulk pharmaceutical purchases with recurring annual volumes, quarterly delivery schedules to specific health facilities, and compliance with workplace, immigration, and federal environmental standards.

The single recent opportunity on record comes from Seminole County, Florida, an IFB released June 30, 2026 with a response deadline of July 26, 2023 (note the conflicting dates in the source). Seminole County sought 1,900 units of naloxone and 800 drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to submit electronically, include all shipping and delivery costs in their bids, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace requirements. The contract structure included a two-year initial term with an optional one-year renewal and a three-month probationary period allowing termination at will. Activity under this code appears limited; the single tracked opportunity does not establish a clear pattern of frequent solicitation across multiple jurisdictions.